Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Criteria Optimized for Microscopy Following Automated Urine Analysis

By LabMedica International staff writers
Posted on 05 Nov 2014
Urinalysis (UA) is one of the most requested routine tests in clinical laboratories and is very useful in screening, diagnosing, and monitoring many diseases and is not limited in scope to diseases directly involving the urinary tract.

Fully automated integrated urine analyzers analyze all physical and chemical characteristics of urine and sediments in urine on a single platform; however some formed elements present in urine, casts for example, require manual microscopic examination of the urine sample following the use of the automated urine analyzer.

Clinical pathologists at the Siriraj Hospital (Bangkok, Thailand) randomly selected 399 samples from leftover routine urinalysis specimens in order to establish the threshold of each parameter that achieved the highest efficiency. More...
A validation set of 599 samples was then used to apply the criteria previously established. All samples were evaluated for incongruent results between the results from both components of a fully automated integrated urine analyzer for both chemical analysis (CHM) and, flow cytometry (FCM) and manual microscopic examination.

After concentration, the urine samples were examined under a CX 31 light microscope (Olympus, Tokyo, Japan). The UX-2000 fully automated integrated urine analyzer (Sysmex Corporation; Kobe, Japan) was used. This device can evaluate all physical, chemical, and sedimentary properties of urine. This instrument is made up of two analysis components. The chemical (CHM) analysis component analyzes the physical and chemical characteristics of urine. The flow cytometry (FCM) analysis component analyzes urine sedimentary content.

The investigators set 11 criteria rules for optimization. From 399 samples used in optimizing the criteria, 164 (41.1%) were positive. Among the positive samples, one (0.61%) had five parameter abnormalities, three (1.83%) had four parameter abnormalities, 15 (9.15%) had three parameter abnormalities, 63 (38.41%) had two parameter abnormalities, and 82 (50%) had one parameter abnormality. For microscopic review, they found a total of 270 occurrences from 164 samples: 48 with red blood cells (RBC), 63 with leukocytes (WBC), 10 with epithelial cells (EC), 110 with bacteria, two yeasts, five hyaline casts, 16 pathological casts, 13 with crystals, and three with small round cells (SRC).

The authors concluded that the Sysmex UX-2000 cannot completely replace microscopy, especially for abnormal urinalysis. A viable option is the combination of both the UX-2000 and manual microscopic methods to obtain the best results. This combination can minimize or eliminate error in urine preparation and can also provide flagging for alerting operators when a specimen must be confirmed by manually processing. Therefore, if the UX-2000 is used in the laboratory, it is recommended that the laboratory develop its own criteria for dictating protocols and requirements relating to manual processing. The study was published October 2, 2014, in the journal Clinica Chimica Acta.

Related Links:

Siriraj Hospital 
Olympus 
Sysmex Corporation 



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.